Results for tag: "Mepolizumab"

Mepolizumab is a monoclonal antibody used to treat severe asthma and chronic obstructive pulmonary disease (COPD). It works by targeting and blocking the action of interleukin-5, a protein that plays a role in the inflammation associated with these conditions. Mepolizumab is administered as an intravenous infusion or subcutaneous injection. It is approved for use in adults and adolescents aged 12 and over. Mepolizumab is a relatively new drug in the respiratory market, but it has been gaining traction in recent years. It is used to treat severe asthma and COPD, two of the most common respiratory diseases. It is also used to reduce exacerbations in patients with severe asthma. Mepolizumab is generally well-tolerated and has been shown to improve lung function and reduce the need for oral corticosteroids. Some of the companies in the Mepolizumab market include GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. Show Less Read more